CONDENSED BALANCE SHEETS - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Current asset    
Cash $ 408,543 $ 194,970
Prepaid expenses 146,896 0
Total Current Assets 555,439 194,970
Deferred offering costs 0 85,938
Deferred tax asset 196 0
Marketable securities held in Trust Account 76,522,615 0
TOTAL ASSETS 77,078,250 280,908
Current liabilities    
Accounts payable and Accrued expenses 124,689 1,564
Accrued offering costs 0 55,938
Promissory note - Related party 0 200,000
Total Current Liabilities 124,689 257,502
Deferred underwriting fee payable 2,677,500 0
Total Liabilities 2,802,189 257,502
Commitments
Common stock subject to possible redemption, 6,927,606 shares at redemption value at September 30, 2020 69,276,060 0
Stockholders' Equity    
Common stock, $0.0001 par value; 50,000,000 shares authorized; 2,900,394 and 2,156,250 shares issued and outstanding (excluding 6,927,606 and no shares subject to possible redemption) as of September 30, 2020 and December 31, 2019 (1) [1] 290 216
Additional paid-in capital 5,225,337 24,784
Accumulated deficit (225,626) (1,594)
Total Stockholders' Equity 5,000,001 23,406
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 77,078,250 $ 280,908
[1] Included an aggregate of up to 281,250 shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters (see Note 5).